« zurück zur News-Übersicht

Jul 03, 2013
Cooperation with Munich Technical University Hospital to Develop Novel Anti-Infectives Extended

Munich, Germany, July 3, 2013 - Priaxon AG, Munich, and the University Hospital Rechts der Isar (Technical University Munich) have successfully been cooperating on the development of new, highly selective anti-infective agents against a novel protein target class of widely spread infectious diseases for the last three years. After this first funding period the results have been evaluated and a second funding period of two years has been granted.

The joint project is supported in the framework of the top cluster support project of the German Federal Ministry of Education and Research, coordinated by BioM GmbH. In the context of this top cluster support the Munich biotech region was awarded altogether EUR 40 mio., doubled by an additional amount of EUR 40 mio. in industry funding, and further raised by approx. EUR 12 mio. from the Free State of Bavaria, over a funding period of five years.